Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.9.3993

Diabetes Mellitus as a Risk Factor for High Grade Renal Cell Carcinoma  

Otunctemur, Alper (Department of Urology, Okmeydani Training and Research Hospital)
Ozbek, Emin (Department of Urology, Ataturk Training and Research Hospital, Katip Celebi University)
Sahin, Suleyman (Department of Urology, Okmeydani Training and Research Hospital)
Dursun, Murat (Department of Urology, Bahcelievler State Hospital)
Besiroglu, Huseyin (Department of Urology, Okmeydani Training and Research Hospital)
Koklu, Ismail (Department of Urology, Okmeydani Training and Research Hospital)
Erkoc, Mustafa (Department of Urology, Okmeydani Training and Research Hospital)
Danis, Eyyup (Department of Urology, Okmeydani Training and Research Hospital)
Bozkurt, Muammer (Department of Urology, Okmeydani Training and Research Hospital)
Gurbuz, Ahmet (Department of Urology, Okmeydani Training and Research Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.9, 2014 , pp. 3993-3996 More about this Journal
Abstract
Background: Diabetes is a chronic disease characterized by impaired fasting blood glucose that leads to disturbances in various organs. In this study, we evaluated relationships between tumor size and grade in a population of diabetic and non-diabetic patients with renal cell carcinoma. Materials and Methods: Between 2007-2013, in our clinic radical nephrectomy performed to 310 patients for renal tumors and pathology reported renal cell carcinoma cases were enrolled in the study. Patients with and without a history of diabetes regarding fasting glucose and HgA1c levels were evaluated during surgery for tumor size and Fuhrman grade. Results: Diabetes was found in 95 patients. The mean age of the patients with and without diabetes mellitus was 64.3 (40-79) and 58.4 (31-87) years, respectively. In the diabetes group 51% of patients had a tumor size over 7 cm and 54% a tumor grade over Fuhrman 3. The respective figures in the non-diabetes group were 35% and 30% (p<0.05 in both cases). Conclusions: Renal cancer appears more aggressive in patients with diabetes. In this study lifestyle and risk factors with diabetes regulation were observed to be important for renal cancer patients. Multicenter studies are needed in larger series for more accurate results.
Keywords
Diabetes; renal cell carcinoma; tumor size; Furhman grade; HgA1c;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Washio M, Mori M, Mikami K (2013). Cigarette smoking and other risk factors for kidney cancer death in a Japanese population: Japan Collaborative Cohort Study for evaluation of cancer risk (JACC study). Asian Pac J Cancer Prev, 14, 6523-8.   과학기술학회마을   DOI   ScienceOn
2 Wallen EM, Pruthi RS, Joyce GF, Wise M (2007). Urologic Diseases in America Project. J Urol, 177, 2006-18.   DOI   ScienceOn
3 Weikert S, Ljungberg B (2010). Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention. World J Urol, 28, 247-52.   DOI   ScienceOn
4 Lee S, Hong SK, Kwak C, Kim HH, Lee SE (2012). Prognostic significance of diabetes mellitus in localized renal cell carcinoma. Jpn J Clin Oncol, 42, 318-24.   DOI   ScienceOn
5 Lindblad P, Chow WH, Chan J, et al (1999). The role of diabetes mellitus in the etiology of renal cell cancer. Diabetologia, 42, 107-12.   DOI
6 Lowrance WT, Thompson RH, Yee DS, et al (2009). Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies. BJU Int, 105, 16-20.
7 Larsson SC, Wolk A (2011). Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies. Diabetologia, 54, 1013-8.   DOI
8 Miyajima A, Asano T, Seta K, et al (2003). Loss of expression of transforming growth factor-beta receptor as a prognostic factor in patients with renal cell carcinoma. Urology, 61, 1072-7.   DOI   ScienceOn
9 Ozbek E, Otunctemur A, Dursun M, et al (2014). Association between the metabolic syndrome and high tumor grade and stage of primary urothelial cell carcinoma of the bladder. Asian Pac J Cancer Prev, 15, 1447-51.   과학기술학회마을   DOI   ScienceOn
10 Parker AS, Cheville JC, Blute ML, et al (2004). Pathologic T1 clear cell renal cell carcinoma: insulin-like growth factor-I receptor expression and disease-specific survival. Cancer, 100, 2577-82.   DOI   ScienceOn
11 Rodriguez C, Patel AV, Mondul AM, et al (2005). Diabetes and risk of prostate cancer in a prospective cohort of US men. Am J Epidemiol, 161, 147-52.   DOI   ScienceOn
12 Sonksen PH, Russell-Jones D, Jones RH (1993). Growth hormone and diabetes mellitus. A review of sixty-three years of medical research and a glimpse into the future? Horm Res, 40, 68-79.   DOI   ScienceOn
13 Schlehofer B, Pommer W, Mellemgaard A, et al (1996). International renal cell cancer study VI. The role of medical and family history. Int J Cancer, 66, 723-6.   DOI
14 Anderson GF, Chu E (2007). Expanding priorities-confronting chronic disease in countries with low income. N Engl J Med, 356, 209-11.   DOI   ScienceOn
15 Bruce WR, Giacca A, Medline A (2000). Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol Biomarkers Prev, 9, 1271-9.
16 Czyzyk A, Szczepanik Z (2000). Diabetes mellitus and cancer. Eur J Intern Med, 11, 245-52.   DOI   ScienceOn
17 Chow WH, Dong LM, Devesa SS (2010). Epidemiology and risk factors for kidney cancer. Nat Rev Urol, 7, 245-57.   DOI   ScienceOn
18 Choi JB, Yoon BI, Kim SJ, et al (2011). Changes in clinicopathological characteristics of renal cell carcinoma in the past 25 years: a single-center experience. Korean J Urol, 52, 110-4.   DOI   ScienceOn
19 Farag YM, Gaballa MR (2011). Diabesity: an overview of a rising epidemic. Nephrol Dial Transplant, 26, 28-35.   DOI   ScienceOn
20 Giovannucci E (2001). Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr, 131, 3109-20.   DOI
21 Gupta SP, Mittal A, Jha DK, Pandeya DR, Sathian B (2012). Diabetes mellitus and renal cell carcinoma--a hospital based study from Kathmandu Valley. Asian Pac J Cancer Prev, 13, 4963-5.   과학기술학회마을   DOI
22 Habib SL, Prihoda TJ, Luna M, Werner SA (2012). Diabetes and risk of renal cell carcinoma. J Cancer, 3, 42-8.   DOI   ScienceOn
23 Jee SH, Ohrr H, Sull JW, et al (2005). Fasting serum glucose level and cancer risk in Korean men and women. JAMA, 293, 194-202.   DOI   ScienceOn
24 Jemal A, Siegel R, Ward E, et al (2007). Cancer statistics, 2007. CA Cancer J Clin, 57, 43-66.   DOI   ScienceOn
25 Wideroff L, Gridley G, Mellemkjaer L, et al (1997). Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst, 89, 1360-5.   DOI   ScienceOn